Medical Device Imports in Morocco: PortNet, Import Commitment, and Customs
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Importing medical devices into Morocco involves three linked steps: the registration certificate (Article 12 of Law No. 84-12) → the import commitment (engagement d’importation), processed through the PortNet single window and domiciled with the importer’s bank → customs clearance against the registration certificate. Devices without a registration certificate are detained at the port. GRZAN treats these three steps as a single chain: if any link is missing, the goods stop at the port, and the cost of that stoppage — demurrage, storage, missed deliveries — usually exceeds the cost of preparing the chain correctly in the first place.
The chain also allocates responsibilities among parties that a manufacturer must coordinate from abroad. The certificate belongs to the certificate-holding establishment, the import commitment to the importer with its bank, and the clearance process to the appointed clearing agent, while the manufacturer supplies the product documentation, French labelling, and technical files. Successful shipments are therefore a scheduling exercise: each party’s step must be completed in the right order, and the manufacturer’s own deliverables must arrive early enough not to become the bottleneck of the chain.
2. Legal basis
| Instrument | Reference number | Publication date | Provisions |
|---|---|---|---|
| Medical Devices Law (Loi n° 84-12) | Dahir n° 1-13-90 | 30 August 2013 | Article 12 (registration precondition); Article 1, item 9 (definition of import establishments); Article 7 (declaration of import establishments) |
| Moroccan customs and foreign trade regulations (PortNet single window) | No single official reference obtained (this verification) | — | Import commitment and clearance procedures |
Practical estimate: the PortNet operating procedures, the bank domiciliation requirement for the import commitment, and customs clearance against the registration certificate are drawn from consistent industry practice and clearing-agent accounts; they constitute a practical estimate. Specific clearance requirements are subject to confirmation with Moroccan customs and the certificate-holding establishment at the time of each shipment.
3. Expert insights
Insight 1: The registration certificate is the substantive requirement for clearance. Article 12 requires a registration certificate before placing a device on the market, and import is the step that precedes placing on the market. In practice, customs releases consignments against the AMMPS registration certificate, and unregistered devices are detained. This means the sequence of shipping first and obtaining the certificate afterwards does not work in Morocco: the certificate must exist before the goods move. Planning timelines should therefore place registration completion upstream of any shipment booking, not downstream of it.
Insight 2: The import commitment brings the bank into the compliance chain. The import commitment must be processed through the PortNet single window and domiciled with the importer’s bank before payment. This design links foreign-exchange payment to import compliance: if the commitment has not been completed, even the payment leg is blocked. Companies should treat the commitment as a financial-control checkpoint as much as a customs formality, coordinating among the certificate-holding establishment, the bank, and the clearing agent so that payment release and goods release never fall out of step.
Insight 3: The importer’s declared activity type determines whether it may import at all. Import establishments as defined in Article 1, item 9, cover three categories: importers of new devices, of devices refurbished in the country of origin, and of used devices intended for refurbishment. An establishment that declared only distribution has no import status. Checking the AMMPS register for the importer’s declared type therefore belongs at partner selection, before the first purchase order is issued, because the defect cannot be cured by paperwork at the border.
Insight 4: Trade agreements affect cost, not market access. Morocco has free trade agreements with the European Union, the United States, Turkey, and Arab partners (the Agadir Agreement and the Greater Arab Free Trade Area); no free trade agreement exists with China (a Chinese proposal was made in June 2026, and negotiations had not started as of this verification). Free trade agreements affect tariff cost but do not waive the registration obligation of Article 12. This point is a practical estimate, and its commercial significance is that duty planning can be optimised independently, but never substituted, for regulatory planning.
Insight 5: Sample imports under Article 13 follow a separate chain. Evaluation samples, exhibition samples, and similar consignments are imported under a specific authorisation, not under the registration certificate. Clearance documents must match the type of authorisation used; mixing the two chains leads to detention at customs. Companies running evaluation programmes in Morocco should keep sample shipments on their own documentation track, clearly labelled and reconciled against the specific authorisation that covers them.
4. Practical recommendations
- Build the clearance document chain as a checklist. Verify item by item: registration certificate, import commitment, commercial invoice, packing list, certificate of origin, and French-language labelling and instructions for use.
- Complete the import commitment before payment. Confirm the timing with the certificate-holding establishment and the bank to avoid both funds and goods being stuck simultaneously.
- Verify the importer’s declaration type. Confirm in the AMMPS register that the declared activities include import.
- Evaluate free trade agreement benefits separately. Calculate tariff costs under the applicable agreement rules, but never conflate them with the registration obligation.
- Clear samples under the matching authorisation. Use the Article 13 authorisation documents for samples; do not route them through the registration certificate chain.
5. Verification checklist
- □ The imported product holds a valid AMMPS registration certificate
- □ The import commitment has been processed through PortNet and domiciled with the bank
- □ The importer’s declared activity type includes import
- □ The commercial invoice describes the goods completely and in French
- □ Labelling and instructions for use meet the language requirements
- □ Free trade agreement applicability has been assessed (it does not affect the registration obligation)
- □ Sample imports use the corresponding authorisation documents under Article 13
Regulatory information verified as of 30 October 2026
GRZAN supports medical device manufacturers entering the Moroccan market with import chain management, PortNet and customs coordination through local partners, and cost budgeting for registration, import, and maintenance obligations. For support on the requirements described above, contact info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us